share_log

Earnings Miss: Herbalife Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

Earnings Miss: Herbalife Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts

收益不佳:康寶萊有限公司每股收益下降了16%,分析師正在修改預測
Simply Wall St ·  02/17 07:28

Shareholders in Herbalife Ltd. (NYSE:HLF) had a terrible week, as shares crashed 33% to US$8.07 in the week since its latest full-year results. Revenues were in line with forecasts, at US$5.1b, although statutory earnings per share came in 16% below what the analysts expected, at US$1.42 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

康寶萊有限公司(紐約證券交易所代碼:HLF)的股東經歷了糟糕的一週,自公佈最新的全年業績以來,本週股價暴跌33%,至8.07美元。收入與預期一致,爲51億美元,儘管每股法定收益比分析師預期的1.42美元低16%。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

earnings-and-revenue-growth
NYSE:HLF Earnings and Revenue Growth February 17th 2024
紐約證券交易所:HLF收益和收入增長 2024年2月17日

Following last week's earnings report, Herbalife's five analysts are forecasting 2024 revenues to be US$5.09b, approximately in line with the last 12 months. Per-share earnings are expected to soar 43% to US$2.05. In the lead-up to this report, the analysts had been modelling revenues of US$5.14b and earnings per share (EPS) of US$3.07 in 2024. The analysts seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a large cut to EPS estimates.

繼上週的業績之後,康寶萊的五位分析師預測2024年的收入爲50.9億美元,與過去12個月大致持平。每股收益預計將飆升43%,至2.05美元。在本報告發布之前,分析師一直在模擬2024年的收入爲51.4億美元,每股收益(EPS)爲3.07美元。最新業績公佈後,分析師似乎變得更加看跌。儘管收入預測沒有變化,但每股收益的預期已大幅下調。

It might be a surprise to learn that the consensus price target fell 21% to US$13.60, with the analysts clearly linking lower forecast earnings to the performance of the stock price. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Herbalife, with the most bullish analyst valuing it at US$19.00 and the most bearish at US$10.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

得知共識目標股價下跌21%至13.60美元,這可能令人驚訝,分析師明確將較低的預測收益與股價表現聯繫起來。但是,這並不是我們可以從這些數據中得出的唯一結論,因爲一些投資者在評估分析師目標股價時也喜歡考慮估計值的差異。對康寶萊的看法有所不同,最看漲的分析師將其估值爲19.00美元,最看跌的爲每股10.00美元。注意到分析師目標股價的巨大差距了嗎?對我們來說,這意味着基礎業務存在相當廣泛的可能情景。

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's pretty clear that there is an expectation that Herbalife's revenue growth will slow down substantially, with revenues to the end of 2024 expected to display 0.5% growth on an annualised basis. This is compared to a historical growth rate of 1.3% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 7.1% annually. Factoring in the forecast slowdown in growth, it seems obvious that Herbalife is also expected to grow slower than other industry participants.

我們可以從大局的角度看待這些估計值的另一種方式,例如預測如何與過去的表現相提並論,以及預測相對於業內其他公司是否或多或少看漲。很明顯,預計康寶萊的收入增長將大幅放緩,預計到2024年底的收入按年計算將增長0.5%。相比之下,過去五年的歷史增長率爲1.3%。相比之下,該行業的其他公司(根據分析師的預測),後者的總體收入預計每年將增長7.1%。考慮到預計的增長放緩,很明顯,康寶萊的增長速度預計也將低於其他行業參與者。

The Bottom Line

底線

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Herbalife's revenue is expected to perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.

要了解的最重要的一點是,分析師下調了每股收益的預期,這表明公佈這些業績後,市場情緒明顯下降。幸運的是,分析師還重申了他們的收入預期,表明收入符合預期。儘管我們的數據確實表明,康寶萊的收入預計將比整個行業的表現差。此外,分析師還下調了目標股價,這表明最新消息加劇了人們對業務內在價值的悲觀情緒。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Herbalife analysts - going out to 2025, and you can see them free on our platform here.

考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。多位康寶萊分析師估計,到2025年,你可以在我們的平台上免費查看。

Even so, be aware that Herbalife is showing 4 warning signs in our investment analysis , and 2 of those are concerning...

即便如此,請注意,康寶萊在我們的投資分析中顯示出4個警告信號,其中2個與之有關...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論